OVERVIEW: Acorda Therapeutics supports the study and education of neurological and nervous system disorders.
IP TAKE: Though exact grant amounts remain unclear, this is an approachable funder that accepts unsolicited requests for funding.
PROFILE: Acorda Therapeutics, a biotech company developing treatments for multiple sclerosis and spinal cord injuries, does not have a philanthropic arm per se, but it runs a grant program.
Acorda awards grants for neurological research and education “for academic and other medical centers, medical and professional societies and associations, and patient organizations.” Continuing Education Grants fund education that builds upon and improves how neurological disorders are taught.
While it does not specify which neurological disorders it prioritizes, Acorda tends to support work examining nervous system disorders. Acorda is not clear on specific grant amounts. However, it makes awards for a wide range of activities including medical scientific operations, continuing medical education, and investigator initiated studies. It also offers sponsorships to qualified nonprofits working in the fields of neurological research, education, and patient support.
Unsolicited requests for funding are accepted via Acorda’s online application portal. Although there are no deadlines, applications must be submitted at least 60 in advance of the project or program for which the grant is being requested. Submissions made in any another manner than the online application portal will not be accepted.
- Search for staff contact info and bios in PeopleFinder (paid subscribers only.)